,49 Qiu et al reported that NR2F1 was predominantly associated with immunosuppressive cancer-associated fibroblast infiltration, and in vitro experiments revealed that NR2F1 knockdown could suppress cell migration and invasion through the EMT pathway in ovarian cancer patients.50 Here, NR2F1 is linked to ovarian carcinoma.